Advanced Solid Tumors (Excluding Breast Cancer)

Oncology
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Taiho Oncology
Taiho OncologyNJ - Princeton
2 programs
2
TAS-102Phase 11 trial
TAS-102 tabletsPhase 11 trial
Active Trials
NCT01867879CompletedEst. Apr 2015
NCT01874522CompletedEst. Nov 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Taiho OncologyTAS-102 tablets
Taiho OncologyTAS-102

Clinical Trials (2)

NCT01874522Taiho OncologyTAS-102 tablets

Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI

Start: Jul 2013Est. completion: Nov 2015
Phase 1Completed
NCT01867879Taiho OncologyTAS-102

Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors

Start: Jun 2013Est. completion: Apr 2015
Phase 1Completed

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
3h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
3h ago

Office Administrator

SystImmune
3h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
3h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
3h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
3h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)